Malaria

Lancet

Volumn 365, Issue 9469, 2005, Pages 1487-1498

  Greenwood, Brian M ^a   Bojang, Kalifa ^a,b   Whitty, Christopher J M ^a   Targett, Geoffrey A T ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; ARTESUNATE; CHLOROQUINE; CHLORPROGUANIL PLUS DAPSONE; DIHYDROARTEMISININ; DOXYCYCLINE; FANSIDAR; INSECTICIDE; MALARIA VACCINE; MEFLOQUINE; NAPHTHOQUINONE; PIPERAQUINE; QUININE; RETINOL; TRIMETHOPRIM; ZINC;

AFRICA; ANOPHELES GAMBIAE; ANTIBIOTIC RESISTANCE; BED NET; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEATH; DISEASE TRANSMISSION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; ENDEMIC DISEASE; FINANCIAL MANAGEMENT; GENE MUTATION; GENETIC ANALYSIS; GREENHOUSE EFFECT; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INSECT GENETICS; INSECTICIDE RESISTANCE; LAND DRAINAGE; MALARIA; MALARIA CONTROL; MORTALITY; MOSQUITO; PARASITE VIRULENCE; PATHOGENESIS; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM MALARIAE; PLASMODIUM VIVAX; PRIORITY JOURNAL; SEASONAL VARIATION; SIDE EFFECT; TRAVEL; VECTOR CONTROL; VITAMIN SUPPLEMENTATION; WAR; REVIEW;

HUMANS; MALARIA; MALARIA VACCINES;

EID: 17844382146     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66420-3     Document Type: Conference Paper

References (142)

1. S Litsios The tomorrow of malaria 1996 Pacific Press Wellington
2. The Roll Back Malaria Partnership http://www.rbm.who.int (accessed Jan 23, 2005)
3. B Greenwood, T Mutabingwa Malaria in 2002 Nature 415 2002 670 672
4. SI Hay, DJ Rogers, SE Randolph Hot topic or hot air? Climate change and malaria resurgence in East African highlands Trends Parasitol 18 2002 530 534
5. FC Tanser, B Sharp, D le Sueur Potential effect of climate change on malaria transmission in Africa Lancet 362 2003 1792 1798
6. PB Bloland, HA Williams Malaria control during mass population movements and natural disasters 2003 National Academies Press Washington
7. JG Kublin, P Patnaik, CS Jere Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study Lancet 365 2005 233 240
8. J Whitworth, D Morgan, M Quigley Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study Lancet 356 2000 1051 1056
9. N French, J Nakiyingi, E Lugada Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults AIDS 15 2001 899 906
10. AM Mount, V Mwapasa, SR Elliott Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection Lancet 363 2004 1860 1867
11. RW Snow, J-F Trape, K Marsh The past, present and future of childhood malaria mortality in Africa Trends Parasitol 17 2001 593 597
12. EL Korenromp, BG Williams, E Gouws, C Dye, RW Snow Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy Lancet Infect Dis 3 2003 349 358
13. D de Savigny, F Binka Monitoring future impact on malaria burden in sub-Saharan Africa Am J Trop Med Hyg 71 suppl 2 2004 224 231
14. RW Snow, CA Guerra, AM Noor, HY Myint, SI Hay The global distribution of clinical episodes of Plasmodium falciparum malaria Nature 434 2005 214 217
15. Mapping Malaria Risk in Africa http://www.mara.org.za (accessed Jan 23, 2005)
16. London School of Hygiene and Tropical Medicine Deriving mortality and morbidity estimates for common childhood diseases http://www.lshtm.ac.uk/nphiru/ research/cherg.html (accessed Jan 23, 2005)
17. RW Steketee, BL Nahlen, ME Parise, C Menendez The burden of malaria in pregnancy in malaria-endemic areas Am J Trop Med Hyg 64 1-2 suppl 2001 28 35
18. HL Guyatt, RW Snow The epidemiology and burden of Plasmodium falciparum related anemia among pregnant women in sub-Saharan Africa Am J Trop Med Hyg 64 1-2 suppl 2001 36 44
19. HL Guyatt, RW Snow Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa Trans R Soc Trop Med Hyg 95 2001 569 576
20. SI Hay, CA Guerra, AJ Tatem, AM Noor, RW Snow The global distribution and population at risk of malaria: past, present, and future Lancet Infect Dis 4 2004 327 336
21. SD Fernando, DM Gunawardena, MR Bandara The impact of repeated malaria attacks on the school performance of children Am J Trop Med Hyg 69 2003 582 588
22. JA Carter, AJ Ross, BG Neville Developmental impairments following severe falciparum malaria in children Trop Med Int Health 10 2005 3 10
23. RI Chima, CA Goodman, A Mills The economic impact of malaria in Africa: a critical review of the evidence Health Policy 63 2003 17 36
24. J Sachs, P Malaney The economic and social burden of malaria Nature 415 2002 680 685
25. LM Barat, N Palmer, S Basu, E Worrall, K Hanson, A Mills Do malaria control interventions reach the poor? A view through the equity lens Am J Trop Med Hyg 71 suppl 2 2004 174 178
26. COH Jones, HA Williams The social burden of malaria: what are we measuring? Am J Trop Med Hyg 71 suppl 2 2004 156 161
27. DJ Rogers, SE Randolph, RW Snow, SI Hay Satellite imagery in the study and forecast of malaria Nature 415 2002 710 715
28. MC Thomson, SJ Connor The development of malaria early warning systems for Africa Trends Parasitol 17 2001 438 445
29. TA Abeku, SI Hay, S Ochola Malaria epidemic early warning and detection in African highlands Trends Parasitol 20 2004 400 405
30. HD Teklehaimanot, J Schwartz, A Teklehaimanot, M Lipsitch Alert threshold algorithms and malaria epidemic detection Emerg Infect Dis 10 2004 1220 1226
31. KD Vernick, A Waters Genomics and malaria control N Engl J Med 351 2004 1901 1904
32. B Singh, L Kim Sung, A Matusop A large focus of naturally acquired Plasmodium knowlesi infections in human beings Lancet 363 2004 1017 1024
33. ATR Jensen, P Magistrado, S Sharp Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMPI encoded by group A var genes J Exp Med 199 2004 1179 1190
34. T Staalsoe, CE Shulman, JN Bulmer, K Kawuondo, K Marsh, L Hviid Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria Lancet 363 2004 283 289
35. M Marti, RT Good, M Rug, E Kneupfer, AF Cowman Targeting malaria virulence and remodeling proteins to the host erythrocyte Science 306 2004 1930 1933
36. AA Djimdé, AK Doumbo, Traore Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria Am J Trop Med Hyg 69 2003 559 563
37. CJ Sutherland, A Alloueche, J Curtis Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes Am J Trop Med Hyg 67 2002 578 585
38. C Roper, R Pierce, B Bredenkamp Antifolate antimalarial resistance in southeast Africa: a population-based analysis Lancet 361 2003 1174 1181
39. IM Hastings The origins of antimalarial drug resistance Trends Parasitol 20 2004 512 518
40. RL Hallett, CJ Sutherland, N Alexander Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes Antimicrob Agents Chemother 48 2004 3940 3943
41. IM Hastings, WM Watkins, NJ White The evolution of drug resistant malaria: the role of drug elimination half-life Philos Trans R Soc Lond B Biol Sci 357 2002 505 519
42. T Mita, A Kaneko, JK Lum Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi Am J Trop Med Hyg 68 2003 413 415
43. I Felger, B Genton, T Smith, M Tanner, H-P Beck Molecular monitoring in malaria vaccine trials Trends Parasitol 19 2003 60 63
44. A Alloueche, P Milligan, DJ Conway Protective efficacy of the RTS,S/ASO2 Plasmodium falciparum malaria vaccine is not strain specific Am J Trop Med Hyg 68 2003 97 101
45. B Genton, I Betuela, I Felger A recombinant blood-stage vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a Phase 1-2b trial in Papua New Guinea J Infect Dis 185 2002 820 827
46. D Schellenberg, C Menendez, E Kahigwa African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death Am J Trop Med Hyg 61 1999 431 438
47. TE Taylor, WJ Fu, RA Carr Differentiating the pathologies of cerebral malaria by postmortem parasite counts Nat Med 10 2004 143 145
48. J Crawley, S Smith, P Muthinji, K Marsh, F Kirkham Electroencephalographic and clinical features of cerebral malaria Arch Dis Child 84 2001 247 253
49. K Silamut, NH Phu, C Whitty A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain Am J Pathol 155 1999 395 410
50. H Ekvall Malaria and anemia Curr Opin Hematol 10 2003 108 114
51. CS Boutlis, JB Weinberg, J Baker Nitric oxide production and nitric oxide synthase activity in malaria-exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitemia Infect Immun 72 2004 6932 6938
52. KE Lyke, R Burges, Y Cissoko Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls Infect Immun 72 2004 5630 5637
53. AM Dondorp, TT Chau, NH Phu Unidentified acids of strong prognostic significance in severe malaria Crit Care Med 32 2004 1683 1688
54. K Maitland, CR Newton Acidosis of severe falciparum malaria: heading for a shock? Trends Parasitol 21 2005 11 16
55. T Planche, M Onanga, A Schwenk Assessment of volume depletion in children with malaria PLoS Med 1 2004 e18
56. M Amexo, R Tolhurst, G Barnish, I Bates Malaria misdiagnosis: effects on the poor and vulnerable Lancet 364 2004 1896 1898
57. H Reyburn, R Mbatia, C Drakeley Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study BMJ 329 2004 1212 1215
58. J Makani, W Matuja, E Liyombo, RW Snow, K Marsh, DA Warrell Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description QJM 96 2003 355 362
59. JA Berkley, BS Lowe, I Mwangi Bacteremia among children admitted to a rural hospital in Kenya N Engl J Med 352 2005 39 47
60. JA Evans, A Adusei, C Timmann High mortality of infant bacteraemia clinically indistinguishable from severe malaria QJM 97 2004 591 597
61. RP Peters, EE Zijlstra, MJ Schijffelen A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management Trop Med Int Health 9 2004 928 934
62. D Chandramohan, S Jaffar, BM Greenwood Use of clinical algorithms for diagnosing malaria Trop Med Int Health 7 2002 45 52
63. I Bates, V Bekoe, A Asamoa-Adu Improving the accuracy of malaria-related laboratory tests in Ghana Malar J 3 2004 38
64. MH Craig, BL Bredenkamp, CH Williams Field and laboratory comparative evaluation of ten rapid malaria diagnostic tests Trans R Soc Trop Med Hyg 96 2002 258 265
65. A Moody Rapid diagnostic tests for malaria parasites Clin Microbiol Rev 15 2002 66 78
66. East African Network for Monitoring Antimalarial Treatment (EANMAT) The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy Trop Med IntHealth 8 2003 860 867
67. CV Plowe, JG Kublin, FK Dzinjalamala Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study BMJ 328 2004 545 548
68. PG Kremsner, S Krishna Antimalarial combinations Lancet 364 2004 285 294
69. M Mayxay, M Khanthavong, N Lindegardh Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic Clin Infect Dis 39 2004 1139 1147
70. P Piola, C Fogg, F Bajunirwe Supervised versus unsupervised intake of six-dose artemether-lumefantrine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial Lancet 365 2005 1467 1473
71. T Mutabingwa, D Anthony, A Heller Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial Lancet 365 2005 1474 1480
72. AA Omari, C Preston, P Garner Artemether-lumefantrine for treating uncomplicated falciparum malaria Cochrane Database Syst Rev 2 2003 CD003125
73. M Adjuik, P Agnamey, A Babiker Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial Lancet 359 2002 1365 1372
74. CO Obonyo, F Ochieng, WR Taylor Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial Trans R Soc Trop Med Hyg 97 2003 585 591
75. F Nosten, M van Vugt, R Price Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study Lancet 356 2000 297 302
76. SG Staedke, A Mpimbaza, MR Kamya, BK Nzarubara, G Dorsey, PJ Rosenthal Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial Lancet 364 2004 1950 1957
77. Medicines for Malaria Venture http://www.mmv.org (accessed Jan 23, 2005)
78. TH Tran, C Dolecek, PM Pham Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial Lancet 363 2004 18 22
79. A Alloueche, W Bailey, S Barton Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial Lancet 363 2004 1843 1848
80. T Mutabingwa, A Nzila, E Mberu Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania Lancet 358 2001 1218 1223
81. World Health Organization Assessment of the safety of artemisinin compounds in pregnancy 2003 WHO Geneva
82. CJ Whitty, R Allan, V Wiseman Averting a malaria disaster in Africa - where does the buck stop? Bull World Health Organ 82 2004 381 384
83. AM Dondorp, PN Newton, M Mayxay Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials Trop Med Int Health 9 2004 1241 1246
84. JL Vennerstrom, S Arbe-Barnes, R Brun Identification of an antimalarial synthetic trioxolane drug development candidate Nature 430 2004 900 904
85. KJ Arrow, CB Panosian, H Gelband Saving lives, buying time. Economics of malaria drugs in an age of resistance 2004 Institute of Medicine, National Academies Press Washington, DC
86. World Health Organization Scaling up home based care for malaria: from research to implementation 2004 WHO Geneva
87. VM Marsh, WM Mutemi, A Willetts Improving malaria home treatment by training drug retailers in rural Kenya Trop Med Int Health 9 2004 451 460
88. J Connor, N Rafter, A Rodgers Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review Bull World Health Organ 82 2004 935 939
89. KI Barnes, J Mwenechanya, M Tembo Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study Lancet 363 2004 1598 1605
90. Health Protection Agency Malaria guidelines http://www.hpa.org.uk/ infections/topics_az/malaria/guidelines.htm (accessed Jan 23, 2005)
91. Centers for Disease Control and Prevention Malaria http://www.cdc.gov/ malaria (accessed Jan 23, 2005)
92. BM Greenwood The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas Am J Trop Med Hyg 70 2004 1 7
93. LJ Schultz, RW Steketee, A Macheso The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi Am J Trop Med Hyg 51 1994 515 522
94. CE Shulman, EK Dorman, F Cutts Intermittent sulphadoxine- pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial Lancet 353 1999 632 636
95. SJ Rogerson, E Chaluluka, M Kanjala Intermittent sulphadoxine- pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99 Trans R Soc Trop Med Hyg 94 2000 549 553
96. AM Van Eijk, JG Ayisi, FO ter Kuile Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study Trop Med Int Health 9 2004 351 360
97. D Schellenberg, C Menendez, E Kahigwa Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial Lancet 357 2001 1471 1477
98. JJ Massaga, AY Kitua, MM Lemnge Effect of intermittent treatment with amodiaquine on anaemia and malaria fever in infants in Tanzania: a randomised placebo-controlled trial Lancet 361 2003 1853 1860
99. D Schellenberg, C Menendez, JJ Aponte Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial Lancet 365 2005 1481 1483
100. Intermittent Preventive Treatment in Infants Consortium Intermittent preventive treatment in infants (IPTi) with antimalarial drugs delivered through the expanded programme on immunization (EPI) http://www.ipti-malaria.org (accessed Jan 23, 2005)
101. Cisse B, Sokhna CS, Alexander N, Trape J-F, Greenwood BM. A double blind, randomised placebo-controlled trial to measure the potential of sIPT with artesunate plus SP to reduce the malaria burden in Niakhar, rural Senegal. 53rd meeting of the American Society of Tropical Medicine and Hygiene, Miami, Nov 7-11, 2004, abstract 17.
102. Dicko A, Sagara I, Sissoko MS, et al. Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children of 6 months to 10 years in Kambila, Mali. 53rd meeting of the American Society of Tropical Medicine and Hygiene, Miami, Nov 7-11, 2004, abstract 18
103. H Verhoeff, CE West, SM Nzyuko Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial Lancet 360 2002 908 914
104. AH Shankar, B Genton, RD Semba Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial Lancet 354 1999 203 209
105. AH Shankar, B Genton, M Baisor The influence of zinc supplementation on morbidity due to Plasmodium falciparum: a randomized trial in preschool children in Papua New Guinea Am J Trop Med Hyg 62 2000 663 669
106. O Muller, H Becher, AB van Zweeden Effect of zinc supplementation on malaria and other causes of morbidity in West African children: randomised double blind placebo controlled trial BMJ 322 2001 1567 1570
107. PT Brey Anopheles gambiae genome: perspectives for malaria control Mol Cells 15 2003 133 138
108. EA Hallem, N Fox, J Zwiebel, JR Carlson Olfaction: mosquito receptor for human-sweat odorant Nature 427 2004 212 213
109. PG Coleman, L Alphey Editorial: genetic control of vector populations: an imminent prospect Trop Med Int Health 9 2004 433 437
110. L Alphey, CB Beard, P Billingsley Malaria control with genetically manipulated insect vectors Science 298 2002 119 121
111. A Chen, WJ Rogan Nonmalarial infant deaths and DDT use for malaria control Emerg Infect Dis 9 2003 960 964
112. ML Mabaso, B Sharp, C Lengeler Historical review of malarial control in southern Africa with emphasis on the use of indoor residual house-spraying Trop Med Int Health 9 2004 846 856
113. C Lengeler Insecticide-treated bednets and curtains for preventing malaria Cochrane Database Syst Rev 2 2004 CD000363
114. PA Phillips-Howard, BJ Nahlen, MS Kolczak Efficacy of permethrin-treated bed nets in the prevention of mortality in young children in an area of high perennial malaria transmission in western Kenya Am J Trop Med Hyg 68 suppl 4 2003 23 29
115. WA Hawley, PA Phillips-Howard, FO ter Kuile Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in Western Kenya Am J Trop Med Hyg 68 suppl 4 2003 121 127
116. DA Diallo, SN Cousens, N Cuzin-Ouattera, I Nebie, E Ilboudo-Sanogo, F Esposito Child mortality in a West African population protected with insecticide-treated curtains for a period of up to 6 years Bull World Health Organ 82 2004 85 91
117. FN Binka, A Hodgson, M Adjuik, T Smith Mortality in a seven-and-a-half year follow-up of a trial of insecticide-treated mosquito nets in Ghana Trans R SocTrop Med Hyg 96 2002 597 599
118. World Health Organization. Report of the fourth meeting of the global collaboration for development of pesticides for public health WHO 2004; WHO/CDS/WHOPES/GCDPP/2004.8
119. M Rowland, G Downey, A Rab DEET mosquito repellent provides personal protection against malaria: a household randomized trial in an Afghan refugee camp in Pakistan Trop Med Int Health 9 2004 335 342
120. BD Brooke, G Kloke, RH Hunt Bioassay and biochemical analyses of insecticide resistance in southern African Anopheles funestus (Diptera: Culicidae) Bull Entomol Res 91 2001 265 272
121. M Zaim, P Guillet Alternative insecticides: an urgent need Trends Parasitol 18 2002 161 163
122. R Monasch, A Reinisch, R Steketee Child coverage with mosquito nets and malaria treatment from population-based surveys in African countries: a baseline for monitoring progress in roll back malaria Am J Trop Med Hyg 71 suppl 2 2004 232 238
123. JRM Armstrong Schellenberg, S Abdulla, R Nathan Effect of large-scale social marketing of insecticide-treated nets on child survival in rural Tanzania Lancet 357 2001 1241 1247
124. C Curtis, C Maxwell, M Lemnge Scaling-up coverage with insecticide-treated nets against malaria in Africa: who should pay? Lancet Infect Dis 3 2003 304 307
125. JD Sachs, JW McArthur The Millennium Project: a plan for meeting the Millennium Development Goals Lancet 365 2005 347 353
126. VS Moorthy, MF Good, AVS Hill Malaria vaccine developments Lancet 363 2004 150 156
127. SD Polley, L McRobert, CJ Sutherland Vaccination for vivax malaria: targeting the invaders Trends Parasitol 20 2004 99 102
128. B Greenwood, P Alonso Malaria Vaccine Trials Chem Immunol 80 2002 366 395
129. JA Stoute, M Slaoui, DG Heppner A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria N Engl J Med 336 1997 86 91
130. KE Kester, DA McKinney, N Tornieporth Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria J Infect Dis 183 2001 640 647
131. KA Bojang, PJ Milligan, M Pinder Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial Lancet 358 2001 1927 1934
132. PL Alonso, J Sacarlal, JJ Aponte Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial Lancet 364 2004 1411 1420
133. J Schneider, SC Gilbert, TJ Blanchard Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Nat Med 4 1998 397 402
134. RJ Anderson, CM Hannan, SC Gilbert Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus J Immunol 172 2004 3094 3100
135. VS Moorthy, EB Imoukhuede, S Keating Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men J Infect Dis 189 2004 2213 2219
136. VS Moorthy, EB Imoukhuede, P Milligan A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults PLoS Med 1 2004 e33
137. World Health Organization Portfolio of candidate malaria vaccines currently in development http://www.who.int/vaccine_research/documents/en/ malaria_table.pdf October, 2004 (accessed Jan 23, 2005)
138. DJ Pombo, G Lawrence, C Hirunpetcharat Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum Lancet 360 2002 610 617
139. DC Kaslow Transmission-blocking vaccines Chem Immunol 80 2002 287 307
140. Malaria Vaccine Initiative http://www.malariavaccine.org (accessed Jan 23, 2005)
141. The Global Fund http://www.theglobalfund.org (accessed Jan 23, 2005)
142. T Duke Clinical care for seriously ill children in district hospitals: a global public health issue Lancet 363 2004 1922 1923